Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denileukin Diftitox Alone and with ICE in Relapsed ALCL
NCT00801918Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- Dec 2008
- Primary completion
- Dec 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in anaplastic large cell lymphoma (ALCL), sponsored by Columbia University. Planned start Dec 2008; status: withdrawn.
02
Drugs
denileukin diftitox
03
Conditions
anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on NCT00801918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801918.